A. Sarma, “Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India”, apjcc, vol. 8, no. 1, pp. 35-42, Feb. 2023.